Lakewood-Amedex Biotherapeutics Inc., a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, ...

One in six laboratory-confirmed bacteria in 2023 proved resistant to antibiotic treatment, according to the World Health ...

The nasal polyps market presents opportunities with multiple pipeline drugs in various development stages, targeting novel treatment approaches. Focused efforts by key players like AstraZeneca ...

Antimicrobial resistance (AMR) and interventions to mitigate it are multisectoral, exhibiting super-wicked features that ...

Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection models; Progressing a platform of small-molecule enzymatic activators that indu ...

Found in full rigor mortis in the Sudbury jail on Feb. 13, 2021, an inquest now seeks to determine how it can be prevented; ...